Total Funding
50
52
Total FundingPost-IPO Debt raised
Growth Score 50 in past quarter
-19 pts
Heat Score 52 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
62249
Avalon Pharma is a manufacturer of beauty brands and generic prescription medicines.
- Maher Ghannam: President & CEO
- Omar Al Jaroudi: Partner & ChairmanPast Role: Shuaa Capital psc, Chief Executive Officer
About the Company
Avalon Pharma manufactures topical preparations such as creams, lotions, other topical solutions, and cosmetic products. It produces disinfectants, sanitizers, mouthwashes, and a volume of hygiene products. They focus on developing products and formulations that will meet the needs and expectations of customers.